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Control on platelet adhesion and activation events
by selective and specific binding of
plasma protein on peptide-coupled surface
Anu Subramanian and Sanjukta Guha-Thankruta
University of Nebraska–Lincoln, Lincoln, Nebraska, USA
Corresponding author — asubramanian2@unl.edu

Implantable material surfaces suffer from unavoidable major events of blood–biomaterial
interactions leading to thrombus formation and finally foreign material rejection. An albuminated surface can minimize the platelet adhesion and activation that reduces the chance
of thrombus formation. The main objective of our work was to design surfaces having maximum human serum albumin (HSA) binding capacity over other plasma proteins in blood
by covalently grafting custom made peptides having selectivity and specificity towards
HSA. First, silicon wafer surfaces were chemically treated to generate –NH2 terminated selfassembled monolayer (SAM). SAMs were then covalently coupled with (a) peptides using 1ethyl-3-[3-dimethylaminopropyl]carbodiimide
hydrochloride
and
Nhydroxysulfosuccinimide cross-linkers and (b) 2,4,6-tris(dimethylaminomethyl)phenol using
1,4-butanediol diglycidyl ether cross linkers. Each modification step was characterized with
ellipsometry, contact angle measurements and UV–vis spectrophotometry. Peptide- and ligand-coupled surfaces were then incubated in serum for a certain duration and adsorbed
protein then subsequently eluted from the surface to evaluate protein binding properties of
surfaces in terms of OD measurements at 280 nm, SDS–PAGE and ELISA. Albuminated surfaces were finally exposed to platelet rich plasma at 37 °C and morphology of adhered platelets was observed under SEM. An unmodified silicon wafer was considered as the negative
control. Surface modification with peptides and ligand changes polar and apolar components of surfaces, which in turn affects strongly the binding characteristics of those surfaces.
Peptide-coupled surfaces have more polar characteristics than other grafted surfaces and
thereby HSA binding is least affected by hydrophobic interaction from surface. Peptidecoupled surfaces showed maximum binding of HSA over other modified surfaces in this
study. SEM pictures have shown a decrease in platelet adhesion and activation as the polarity of surface and HSA binding capacity of surfaces increased. The results demonstrated that
by controlling surface functionality and polarity, non-specific protein adsorption can be minimized and thereby platelet adhesion and activation can be reduced.

